Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000525583> ?p ?o ?g. }
- W2000525583 endingPage "e111652" @default.
- W2000525583 startingPage "e111652" @default.
- W2000525583 abstract "(131)I-CLR1404 is a small molecule that combines a tumor-targeting moiety with a therapeutic radioisotope. The primary aim of this phase 1 study was to determine the administered radioactivity expected to deliver 400 mSv to the bone marrow. The secondary aims were to determine the pharmacokinetic (PK) and safety profiles of (131)I-CLR1404.Eight subjects with refractory or relapsed advanced solid tumors were treated with a single injection of 370 MBq of (131)I-CLR1404. Whole body planar nuclear medicine scans were performed at 15-35 minutes, 4-6, 18-24, 48, 72, 144 hours, and 14 days post injection. Optional single photon emission computed tomography imaging was performed on two patients 6 days post injection. Clinical laboratory parameters were evaluated in blood and urine. Plasma PK was evaluated on (127)I-CLR1404 mass measurements. To evaluate renal clearance of (131)I-CLR1404, urine was collected for 14 days post injection. Absorbed dose estimates for target organs were determined using the RADAR method with OLINDA/EXM software.Single administrations of 370 MBq of (131)I-CLR1404 were well tolerated by all subjects. No severe adverse events were reported and no adverse event was dose-limiting. Plasma (127)I-CLR1404 concentrations declined in a bi-exponential manner with a mean t½ value of 822 hours. Mean Cmax and AUC(0-t) values were 72.2 ng/mL and 15753 ng • hr/mL, respectively. An administered activity of approximately 740 MBq is predicted to deliver 400 mSv to marrow.Preliminary data suggest that (131)I-CLR1404 is well tolerated and may have unique potential as an anti-cancer agent.ClinicalTrials.gov NCT00925275." @default.
- W2000525583 created "2016-06-24" @default.
- W2000525583 creator A5005344580 @default.
- W2000525583 creator A5013731126 @default.
- W2000525583 creator A5026686829 @default.
- W2000525583 creator A5035945664 @default.
- W2000525583 creator A5041342688 @default.
- W2000525583 creator A5057930855 @default.
- W2000525583 creator A5061373605 @default.
- W2000525583 creator A5065485341 @default.
- W2000525583 creator A5074968918 @default.
- W2000525583 creator A5078538616 @default.
- W2000525583 creator A5083945222 @default.
- W2000525583 creator A5086580950 @default.
- W2000525583 date "2014-11-17" @default.
- W2000525583 modified "2023-10-12" @default.
- W2000525583 title "A Phase 1 Study of 131I-CLR1404 in Patients with Relapsed or Refractory Advanced Solid Tumors: Dosimetry, Biodistribution, Pharmacokinetics, and Safety" @default.
- W2000525583 cites W1946923111 @default.
- W2000525583 cites W1997945349 @default.
- W2000525583 cites W2014642161 @default.
- W2000525583 cites W2014783272 @default.
- W2000525583 cites W2023312215 @default.
- W2000525583 cites W2037211078 @default.
- W2000525583 cites W2058649893 @default.
- W2000525583 cites W2130334935 @default.
- W2000525583 cites W2157907127 @default.
- W2000525583 cites W2161817637 @default.
- W2000525583 doi "https://doi.org/10.1371/journal.pone.0111652" @default.
- W2000525583 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4234270" @default.
- W2000525583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25402488" @default.
- W2000525583 hasPublicationYear "2014" @default.
- W2000525583 type Work @default.
- W2000525583 sameAs 2000525583 @default.
- W2000525583 citedByCount "26" @default.
- W2000525583 countsByYear W20005255832015 @default.
- W2000525583 countsByYear W20005255832016 @default.
- W2000525583 countsByYear W20005255832017 @default.
- W2000525583 countsByYear W20005255832018 @default.
- W2000525583 countsByYear W20005255832019 @default.
- W2000525583 countsByYear W20005255832020 @default.
- W2000525583 countsByYear W20005255832021 @default.
- W2000525583 countsByYear W20005255832022 @default.
- W2000525583 crossrefType "journal-article" @default.
- W2000525583 hasAuthorship W2000525583A5005344580 @default.
- W2000525583 hasAuthorship W2000525583A5013731126 @default.
- W2000525583 hasAuthorship W2000525583A5026686829 @default.
- W2000525583 hasAuthorship W2000525583A5035945664 @default.
- W2000525583 hasAuthorship W2000525583A5041342688 @default.
- W2000525583 hasAuthorship W2000525583A5057930855 @default.
- W2000525583 hasAuthorship W2000525583A5061373605 @default.
- W2000525583 hasAuthorship W2000525583A5065485341 @default.
- W2000525583 hasAuthorship W2000525583A5074968918 @default.
- W2000525583 hasAuthorship W2000525583A5078538616 @default.
- W2000525583 hasAuthorship W2000525583A5083945222 @default.
- W2000525583 hasAuthorship W2000525583A5086580950 @default.
- W2000525583 hasBestOaLocation W20005255831 @default.
- W2000525583 hasConcept C112705442 @default.
- W2000525583 hasConcept C126322002 @default.
- W2000525583 hasConcept C126894567 @default.
- W2000525583 hasConcept C142424586 @default.
- W2000525583 hasConcept C149857219 @default.
- W2000525583 hasConcept C150903083 @default.
- W2000525583 hasConcept C159985019 @default.
- W2000525583 hasConcept C192562407 @default.
- W2000525583 hasConcept C197934379 @default.
- W2000525583 hasConcept C207001950 @default.
- W2000525583 hasConcept C22979827 @default.
- W2000525583 hasConcept C2777807558 @default.
- W2000525583 hasConcept C2780007613 @default.
- W2000525583 hasConcept C2780026642 @default.
- W2000525583 hasConcept C2989005 @default.
- W2000525583 hasConcept C71924100 @default.
- W2000525583 hasConcept C75088862 @default.
- W2000525583 hasConcept C86803240 @default.
- W2000525583 hasConcept C98274493 @default.
- W2000525583 hasConceptScore W2000525583C112705442 @default.
- W2000525583 hasConceptScore W2000525583C126322002 @default.
- W2000525583 hasConceptScore W2000525583C126894567 @default.
- W2000525583 hasConceptScore W2000525583C142424586 @default.
- W2000525583 hasConceptScore W2000525583C149857219 @default.
- W2000525583 hasConceptScore W2000525583C150903083 @default.
- W2000525583 hasConceptScore W2000525583C159985019 @default.
- W2000525583 hasConceptScore W2000525583C192562407 @default.
- W2000525583 hasConceptScore W2000525583C197934379 @default.
- W2000525583 hasConceptScore W2000525583C207001950 @default.
- W2000525583 hasConceptScore W2000525583C22979827 @default.
- W2000525583 hasConceptScore W2000525583C2777807558 @default.
- W2000525583 hasConceptScore W2000525583C2780007613 @default.
- W2000525583 hasConceptScore W2000525583C2780026642 @default.
- W2000525583 hasConceptScore W2000525583C2989005 @default.
- W2000525583 hasConceptScore W2000525583C71924100 @default.
- W2000525583 hasConceptScore W2000525583C75088862 @default.
- W2000525583 hasConceptScore W2000525583C86803240 @default.
- W2000525583 hasConceptScore W2000525583C98274493 @default.
- W2000525583 hasIssue "11" @default.
- W2000525583 hasLocation W20005255831 @default.
- W2000525583 hasLocation W20005255832 @default.
- W2000525583 hasLocation W20005255833 @default.